Detalhe da pesquisa
1.
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.
Ann Hematol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443660
2.
FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL.
Clin Hematol Int
; 4(3): 65-74, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103041